Trials / Unknown
UnknownNCT01730599
A Longitudinal Study in Parkinson's Disease (PD) Patients
A Longitudinal 5 Years Follow up Study in Parkinson's Disease (PD) Patients Carriers of the LRRK2 Gene G2019S Mutation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Other Government
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
This is a longitudinal study in patients with Parkinson's Disease (PD) carriers of a genetic mutation - substitution of gly with ser in position 2019 (G2019S) in the leucine-rich repeat kinase 2 (LRRK2) gene. The purpose of this study is to explore the association between genetic mutations in the known genes and their influence on disease manifestation over few years of follow up
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | neurological exam | motor and cognitive functions |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-06-01
- First posted
- 2012-11-21
- Last updated
- 2012-11-21
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01730599. Inclusion in this directory is not an endorsement.